Nooresh Mirani of AMSEC Research told CNBC-TV18, "Irrespective of the market fall Biocon has sustained well and it has given a major triangle breakout, which has a target implication of Rs 400 in the medium term. One can accumulate the stock at Rs 330 levels looking towards Rs 360 as an immediate target."
The share touched its 52-week high Rs 352 and 52-week low Rs 248 on 14 August, 2013 and 22 August, 2012, respectively. Currently, it is trading 3.62 percent below its 52-week high and 36.79 percent above its 52-week low. Market capitalisation stands at Rs 6,785 crore.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
